New Zealand Formulary
Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

Home > Neuroendocrine

Neuroendocrine Regimens



Adrenocortical carcinoma Regimens


Published

Name
Id
Version
Date
Adrenocortical carcinoma Advanced - EDP [etoposide, DOXOrubicin and cISplatin] and mitotane
587901000210102
1.0.0
04/06/2026

Neuroendocrine carcinoma Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
Neuroendocrine carcinoma Advanced - cARBOplatin and etoposide
265491000210102
1.0.0
11/09/2023
Neuroendocrine carcinoma Advanced - cARBOplatin and oral etoposide
265521000210104
1.0.0
11/09/2023
Neuroendocrine carcinoma Advanced - CETUximab [Q2W] and encorafenib
506321000210105
1.0.0
21/04/2025
Neuroendocrine carcinoma Advanced - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil [bolus and infusion]] [high dose foliNIc acid]
265721000210108
1.0.0
23/04/2026
Neuroendocrine carcinoma Advanced - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid]
587891000210103
1.0.0
04/06/2026
Neuroendocrine carcinoma - cISplatin and etoposide 60/120 chemoradiation
265711000210103
2.0.0
08/05/2026
Neuroendocrine carcinoma - cISplatin and etoposide 80/100 chemoradiation
265701000210100
2.0.0
08/05/2026

Neuroendocrine neoplasm Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
Neuroendocrine neoplasm Advanced - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil [bolus and infusion]] [high dose foliNIc acid]
265731000210105
1.0.0
23/04/2026
Neuroendocrine neoplasm Advanced - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
587881000210100
1.0.0
04/06/2026
Neuroendocrine neoplasm Advanced - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]
506341000210104
2.0.0
01/04/2026

Neuroendocrine tumour Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
Neuroendocrine tumour Advanced - capecitabine and temozolomide [ONCE daily dosing]
506441000210109
1.0.0
08/05/2025
Neuroendocrine tumour Advanced - capecitabine and temozolomide [TWICE daily dosing]
587861000210108
1.0.0
04/06/2026
Neuroendocrine tumour Advanced - capecitabine and temozolomide [TWICE daily dosing for use with PRRT]
587871000210102
1.0.0
04/06/2026
Neuroendocrine tumour Advanced - everolimus
265511000210109
1.0.0
11/09/2023
Neuroendocrine tumour Advanced - lanreotide
506361000210103
1.0.0
28/04/2025
Neuroendocrine tumour Advanced - octreotide modified release
components ▾
506941000210103
1.0.0
04/06/2026
octreotide modified release 20 mg Q4W
506951000210100
0.0.8
octreotide modified release 30 mg Q4W
506961000210102
0.0.8
octreotide modified release 10 mg Q4W
506971000210108
0.0.3
octreotide modified release 40 mg Q4W
506981000210105
0.0.9
octreotide modified release 50 mg Q4W
506991000210107
0.0.5
octreotide modified release 60 mg Q4W
507001000210102
0.0.8
octreotide modified release 10 mg Q3W
507011000210100
0.0.3
octreotide modified release 20 mg Q3W
507021000210105
0.0.3
octreotide modified release 30 mg Q3W
507031000210107
0.0.3
octreotide modified release 40 mg Q3W
507041000210104
0.0.3
octreotide modified release 10 mg Q2W
587831000210104
0.0.3
octreotide modified release 20 mg Q2W
587841000210107
0.0.3
octreotide modified release 30 mg Q2W
587851000210105
0.0.4
Neuroendocrine tumour Advanced - peptide receptor radionuclide therapy [PRRT] for pheochromocytoma/paraganglioma
587911000210100
1.0.0
04/06/2026
Neuroendocrine tumour PANC Advanced - leNVAtinib
506931000210106
1.0.0
04/06/2026
Neuroendocrine tumour PANC Advanced - sUNITinib
265501000210107
1.0.0
11/09/2023